Johnson & Johnson's Imbruvica Scores Expanded FDA Approval for Chronic Graft vs Host Disease Post author:Sam Post published:August 2, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like <b>Feldan Therapeutics</b> Announces Issuance Of First Patent For Its Peptide-Based Protein Delivery Technology, The Feldan Shuttle August 22, 2017 <b>ClassPass</b> Raises $70 Million In Series C Funding Led By Temasek Life Science Ventures Pte Ltd (TLV) Following Its Strongest Quarter To Date June 18, 2017 Jobs Lost as Cellectar Biosciences Shutters Manufacturing Operations January 8, 2018
<b>Feldan Therapeutics</b> Announces Issuance Of First Patent For Its Peptide-Based Protein Delivery Technology, The Feldan Shuttle August 22, 2017
<b>ClassPass</b> Raises $70 Million In Series C Funding Led By Temasek Life Science Ventures Pte Ltd (TLV) Following Its Strongest Quarter To Date June 18, 2017